Back
AUTHORIZATION
100% confidence
via regex
GAZETTE NOTICE NO. 1879
GAZETTE NOTICE NO. 1879
THE PHARMACY AND POISONS ACT
(Cap. 244)
AUTHORIZATION
IT IS notified that Form 1: Application for Registration of a dietary supplement or borderline substance has been revised in accordance with the provisions of the Pharmacy and Poisons Act (Cap
244), The Pharmacy and Poisons (Registration of Drugs) Rules, Legal
Notice Number 192 of 2010.
The template application form below prescribes the minimum information required for submission of dossiers for registration of a dietary supplement or borderline substance seeking marketing authorization in Kenya. The dossiers should be submitted to the following address:
The Registrar, Pharmacy and Poisons Board
Lenana Road, P. O. Box 27663-00506, NAIROBI, KENYA
For purposes of submission to PPB, an application for registration of herbal and complementary product shall include:
(a) One duly filled application submitted as an electronic copy including their supporting documents - see Annex I:
Application Form For Registration of Dietary Supplement or
Borderline Substance below
(b) Three (3) samples of the commercial pack(s).
(c) Payment of requisite application fees described in the guideline document for dietary supplement or borderline substance issued by the Pharmacy and Poisons Board.
(d) Any other information required and described in the guideline document for dietary supplement or borderline substance issued by the Pharmacy and Poisons Board.
ANNEX I: APPLICATION FORM FOR REGISTRATION OF
DIETARY SUPPLEMENT OR BORDELINE SUBSTANCE
(to be submitted as an electronic copy)
SECTION 1: PARTICULARS OF THE APPLICANT (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board from time to time)
SECTION 2: PARTICULARS OF THE DIETARY SUPPLEMENT
OR BORDELINE SUBSTANCE (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board)
SECTION 3: PARTICULARS OF THE MANUFACTURER(S) AND
ACTIVITY DONE AT THE MANUFACTURING SITE(S) (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and
Poisons Board)
SECTION 4: COMPOSITION OF THE FINISHED PRODUCT (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and
Poisons Board)
SECTION 5: QUALITY SPECIFICATIONS AND ANALYTICAL
PROCEDURES FOR ALL RAW MATERIALS USED IN THE
PRODUCT (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board from time to time)
SECTION 6: QUALITY SPECIFICATIONS AND ANALYTICAL
PROCEDURES OF THE FINISHED PRODUCT (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board from time to time)
SECTION 7: QUALITY SPECIFICATION AND ANALYTICAL
PROCEDURES FOR THE PACKAGING MATERIAL USED IN
THE FINISHED PRODUCT (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board from time to time)
THE KENYA GAZETTE 21st March, 2014
740 740
SECTION 8: DETAILS OF THE MANUFACTURE AND
PACKAGING OF THE FINISHED PRODUCT (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board from time to time)
SECTION 9: STABILITY STUDIES OF THE FINISHED PRODUCT
(as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and
Poisons Board from time to time)
SECTION 10: SAFETY AND POST MARKET SURVEILLANCE
PLAN OF THE FINISHED PRODUCT (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board from time to time)
SECTION 11: ANY OTHER REFERENCE TO SUPPORT THE
APPLICATION (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board from time to time)
SECTION 12: DECLARATION BY AN APPLICANT which must be signed, dated and authenticated by an Official stamp. No received without properly authenticated declaration.
• I, the undersigned certify that all the information in this form and accompanying documentation is correct, complete and true to the best of my knowledge.
• I further confirm that the information referred to in my application file is available for verification during GMP inspection.
• I also agree that I am obliged to follow the requirements of the
Pharmacy and Poisons Board which are related to dietary supplement or borderline substance.
• I also agree that the undersigned has not marketed or advertised this product in Kenya and will follow the PPB requirements for advertisements of medicines
• I also agree that the undersigned will implement a Post-Market
Surveillance plans for this product in accordance with PPB requirements
• I also consent to the evaluation of information provided to the
Pharmacy and Poisons Board.
Name: ………… ……………………………………………..............…
Position in the company: ………… …....…………………............……
Signature and Date: …………………………………………………
Official stamp: ………… ………………………………...........………
Dated the 8th January, 2014.
K. C. KOSKEI, MR/4648206 Registrar.
Dated the 8th January, 2014.
K. C. KOSKEI,
Registrar.
Extracted Entities (1)
previous_gazette_ref
1879
Details
- Act / Legislation
- THE PHARMACY AND POISONS ACT
- Reference
- Cap. 244
- Section
- section 1
- Signed By
- K. C. KOSKEI
- Title
- Registrar
- Date Signed
- 8th January 2014
- Page
- 35
- Extraction Method
- regex
Source Gazette
Vol. CXVI No. 37
Published 21st March 2014